Biocare Copenhagen A/S   Report issue

For profit Phase 2
Founded: Copenhagen Denmark (2012)
Status: Acquired by DSM (2017) → now Thermo Fisher Scientific (2017)

Organization Overview

First Clinical Trial
2016
NCT02839239
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

Lactobacillus acidophilus (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2